Peptides that mimic the group B streptococcal type III capsular polysaccharide antigen

Journal of Immunology

Volumn 160, Issue 1, 1998, Pages 293-298

  Pincus, Seth H ^a   Smith, Michael J ^a   Jennings, Harold J ^b   Burritt, James B ^a   Glee, Pati M ^a  

^a MONTANA STATE UNIVERSITY   (United States)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; POLYSACCHARIDE; STREPTOCOCCUS ANTIGEN; STREPTOCOCCUS VACCINE; SYNTHETIC PEPTIDE;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIGENICITY; ARTICLE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; SUBCUTANEOUS DRUG ADMINISTRATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BACTERIAL CAPSULES; EPITOPE MAPPING; MICE; PEPTIDE LIBRARY; PEPTIDES; STREPTOCOCCUS AGALACTIAE;

EID: 0031882455     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Centers for Disease Control and Prevention. 1996. Prevention of perinatal group B streptococcal disease: a public health perspective. Morbid. Mortal. Wk. Rep. 45:1.
2. Baker, C. J., and D. L. Kasper. 1976. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N. Engl. J. Med. 294:753.
3. Baker, C. J., and D. L. Kaspar. 1977. Immunologic investigation of infants with septicemia or meningitis due to group B streptococcus. J. Infect. Dis. 136:598.
4. Hemming, V. G., R. T. Hall, P. G. Rhodes, A. O. Shigeoka, and H. R. Hill. 1976. Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence. J. Clin. Invest. 58:1379.
5. Baker, C. J., M. A. Rench, M. S. Edwards, K. J. Carpenter, B. M. Hays, and D. L. Kasper. 1988. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. N. Engl. J. Med. 319:1180.
6. Kasper, D. L., L. C. Paoletti, M. R. Wessels, H.-K. Guttormsen, V. J. Carey, H. J. Jennings, and C. J. Baker. 1996. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J. Clin. Invest. 98:2308.
7. Schneerson, R., J. B. Robbins, J. C. Parke, C. Bell, J. J. Schlesselman, A. Sutton, Z. Wang, G. Schiffman, A. Karpas, and J. Shiloach. 1986. Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilu influenzae type b and Pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates. Infect. Immun. 52:519.
8. Westerink, M. A. J., P. C. Giardina, M. A. Apicella, and T. Kieber-Emmons. 1995. Peptide mimicry of the meningococcal group C capsular polysaccharide. Proc. Natl. Acad. Sci. USA 92:4021.
9. Smith, G. P., and J. K. Scott. 1992. Peptide-display phage libraries. Methods Enzymol. 217:228.
10. Burritt, J. B., C. W. Bond, K. W. Doss, and A. J. Jesaitis. 1996. Filamentous phage display of oligopeptide libraries. Anal. Biochem. 338:1.
11. Oldenberg, K. R., D. Loganathan, I. J. Goldstein, and P. G. Schultz. 1992. Peptide ligands for a sugar-binding protein isolated from a random peptide library. Proc. Natl. Acad. Sci. USA 89:5393.
12. Harris, S. L., L. Craig, J. S. Mehroke, M. Rashed, M. B. Zwick, K. Kenar, E. J. Toone, N. Greenspan, F.-I. Auzanneau, J.-R. Marino-Albernas, B. M. Pinto, and J. K. Scott. 1997. Exploring the basis of peptide-carbohydrate crossreactivity: evidence for discrimination by peptides between closely related anti-carbohydrate antibodies. Proc. Natl. Acad. Sci. USA 94:2454.
13. Hoess, R., U. Brinkmann, T. Handel, and I. Pastan. 1993. Identification of a peptide which binds to the carbohydrate-specific monoclonal antibody B3. Gene 128:43.
14. Christensen, R. D., G. Rothstein, H. R. Hill, and S. H. Pincus. 1983. The effect of hybridoma antibody administration upon neutrophil kinetics during experimental type III group B streptococcal sepsis. Pediatr. Res. 17:795.
15. Pincus, S. H., A. O. Shigeoka, A. A. Moe, L. P. Ewing, and H. R. Hill. 1988. Protective efficacy of IgM monoclonal antibodies in experimental group B streptococcal infection is a function of antibody avidity. J. Immunol. 140:2779.
16. Shigeoka, A. O., S. H. Pincus, N. S. Rote, and H. R. Hill. 1984. Protective efficacy of hybridoma type-specific antibody against experimental infection with group-B Streptococcus. J. Infect. Dis. 149:363.
17. Han, Y., and J. E. Cutler. 1995. Antibody response that protects against disseminated candidiasis. Infect. Immun. 63:2714.
18. Pincus, S. H., R. L. Cole, E. M. Hersh, D. Lake, Y. Masuho, P. J. Durda, and J. McClure. 1991. In vitro efficacy of anti-HIV immunotoxins targeted by various antibodies to the envelope protein. J. Immunol. 146:4315.
19. Pincus, S. H., R. L. Cole, E. Kamanga-Sollo, and S. H. Fischer. 1993. Interaction of group B streptococcal opacity variants with the host defense system. Infect. Immun. 61:3761.
20. Pincus, S. H., R. L. Cole, M. R. Wessels, M. D. Corwin, E. Kamanga-Sollo, S. F. Hayes, W. Cieplak, Jr., and J. Swanson. 1992. Group B streptococcal opacity variants. J. Bacteriol. 174:3739.
21. Lancetield, R. C., and E. H. Freimer. 1966. Type specific polysaccharide antigens of group B streptococci. J. Hyg. 64:191.
22. Burritt, J. B., M. T. Quinn, M. A. Jutila, C. W. Bond, and A. J. Jesaitis. 1995. Topological mapping of neutrophil cytochrome B epitopes with phage-display libraries. J. Biol. Chem. 270:16974.
23. Mohle-Boetani, J. C., A. Schuchat, B. D. Plikaytis, J. D. Smith, and C. V. Broome. 1993. Comparison of prevention strategies for neonatal group B streptococcal infection. JAMA 270:1442.
24. Shigeoka, A. O., S. H. Pincus, N. S. Rote, D. G. Pritchard, J. I. Santos, and H. R. Hill. 1985. Monoclonal antibody preparations for immunotherapy of experimental GBS infection. Antibiot. Chemother. 35:254.
25. Egan, M. L., D. G. Pritchard, H. C. Dillon, and B. M. Gray. 1983. Protection of mice from infection with type III group B streptococcus using monoclonal antibodies. J. Exp. Med. 158:1006.
26. Raff, H. V., P. J. Siscoe, E. A. Wolff, G. Maloney, and W. Shuford. 1988. Human monoclonal antibodies to group B streptococcus. J. Exp. Med. 168:905.
27. Lancefield, R. C., M. McCarty, and W. N. Everly. 1975. Multiple mouse-protective antibodies directed against group B streptococci. J. Exp. Med. 142:165.
28. Wessels, M. R., L. C. Paoletti, D. L. Kasper, J. L. DiFabio, F. Michon, K. Holme, and H. J. Jennings. 1990. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. J. Clin. Invest. 86: 1428.
29. McNamara, M. K., R. E. Ward, and H. Kohler. 1984. Monoclonal idiotype vaccine against Streptococcus pneumonia infection. Science 226:1325.
30. Schreiber, J. R., G. B. Pier, M. Grout, K. Nixon, and M. Patawaran. 1991. Induction of opsonic antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide by an anti-idiotypic monoclonal antibody. J. Infect. Dis. 164:507.
31. Kaack, M. B., L. N. Martin, S. B. Svenson, G. Baskin, R. H. Steele, and J. A. Roberts. 1993. Protective anti-idiotype antibodies in the primate model of pyelonephritis. Infect. Immun. 61:2289.
32. Manafo, W. J., N. S. Greenspan, J. A. Cebra-Thomas, and J. M. Davie. 1987. Modulation of the murine immune response to streptococcal group A carbohydrate by immunization with monoclonal anti-idiotope. J. Immunol. 139:2702.
33. Pincus, S. H., C. J. Stocks, Jr., and L. P. Ewing. 1982. Monoclonal anti-(T,G)-A-L antibodies: characterization of fine specificity and idiotype expression. Mol. Immunol. 19:1551.